Global Artificial Intelligence AI In Respiratory Diseases Market Report 2024

Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2024 – By Imaging Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)), By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By End Use (Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Artificial Intelligence (AI) In Respiratory Diseases Market Definition And Segments

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.

The main imaging types of artificial intelligence (AI) in respiratory diseases are magnetic resonance imaging (MRI), computed tomography (CT) scan, and electronic patient-reported outcomes (ePRO). AI in chronic obstructive pulmonary disease refers to the application of artificial intelligence (AI) technologies in the diagnosis, management, and treatment of COPD. It is used for the treatment of various indications such as chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary infection, by several end-users, including hospital, diagnostic centers, ambulatory surgical centers, and others.

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

The AI in respiratory diseases market size has grown strongly in recent years. It will grow from $7.25 billion in 2023 to $7.66 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing government regulations, growing environmental concerns, increasing aging population, growing patient-centric healthcare approaches, rise in healthcare infrastructure development.

The AI in respiratory diseases market size is expected to see steady growth in the next few years. It will grow to $9.35 billion in 2028 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring.

AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution

Growing environmental pollution is expected to propel the growth of artificial intelligence (AI) in the respiratory disease market going forward. Environmental pollution refers to the addition of any substance or form of energy to the environment at a rate faster than it can be dispersed or stored in a harmless form. AI in respiratory diseases has the potential to significantly reduce the impact of environmental pollution on respiratory health by offering real-time monitoring, personalized risk assessments, informed decision-making, and innovative solutions for both individuals and communities. For instance, in November 2023, according to the United States Environmental Protection Agency, a US-based government agency, in the US around 66 million tons of pollution was emitted into the atmosphere in 2022. Further, US greenhouse gas emissions by the economic sector increased by 6,025.97 million metric tons (MMT) of CO2 in 2020 to 6,340.23 million metric tons (MMT) of CO2 in 2021. Therefore, growing environmental pollution is driving the growth of artificial intelligence (AI) in the respiratory disease market.

Major companies operating in the artificial intelligence (AI) in respiratory diseases market are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management

Major companies operating in artificial intelligence (AI) in the respiratory diseases market are developing innovative products such as N-Tidal devices to monitor patients' tidal breathing. The n-Tidal device measures the volume of air exchanged during normal breathing and provides valuable information about lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology for chronic obstructive pulmonary disease (COPD) diagnosis and management. The technology combines N-Tidal's CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to improve the diagnosis and management of this respiratory condition. Clinical studies have demonstrated the technology's high accuracy, and it is expected to reform the diagnostic process for respiratory diseases. The launch is a significant development in the use of AI for respiratory disease assessment, offering a more comfortable and efficient alternative to existing diagnostic tests.

Resmed Inc. Expands Sleep And Respiratory Care Portfolio With Acquisition Of Somnoware

In July 2023, ResMed Inc., a US-based medical equipment company that provides cloud-connectable medical devices, acquired Somnoware for an undisclosed amount. This acquisition strengthens ResMed's sleep and respiratory care portfolio and complements its existing digital respiratory healthcare tools. The acquisition is expected to enhance the management of patient data, ordering of treatment equipment, scheduling appointments, and tracking compliance, ultimately improving patient experience and health outcomes. Somnoware is a US-based cloud-based platform for enhanced respiratory care management and hospital-at-home care.

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in respiratory diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial Intelligence (AI) in respiratory diseases market includes revenues earned by entities by providing services such as AI-assisted imaging analysis, digital pathology platforms, and AI-powered rehabilitation programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in respiratory diseases market also includes sales IoT devices, wearables, and smart inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence (AI) respiratory disease market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) respiratory disease market statistics, including artificial intelligence (AI) respiratory disease industry global market size, regional shares, competitors with an artificial intelligence (AI) respiratory disease market share, detailed artificial intelligence (AI) respiratory disease market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) respiratory disease industry. This artificial intelligence (AI) respiratory disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial Intelligence (AI) In Respiratory Diseases Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $7.66 billion
Revenue Forecast In 2033 $9.35 billion
Growth Rate CAGR of 3.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Siemens Healthineers; Philips Healthcare; General Electric (GE) Healthcare; Verily Life Sciences LLC; DeepMind Health; Merative L.P.; Innovaccer; Freenome; Aidoc Medical; Butterfly Network; Infervision; Imagen Technologies; Caption Health; Gauss Surgical Inc.; Swaasa AI; Inspirata Inc.; VIDA Diagnostics Inc.; Enlitic; Thirona B.v.; ArtiQ; Icometrix; Zynnon AG; Aidence; Arterys; Dectrocel Healthcare; PneumoWave Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Artificial Intelligence (AI) In Respiratory Diseases Market Characteristics

    3. Artificial Intelligence (AI) In Respiratory Diseases Market Trends And Strategies

    4. Artificial Intelligence (AI) In Respiratory Diseases Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Artificial Intelligence (AI) In Respiratory Diseases Market Size and Growth

    5.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Artificial Intelligence (AI) In Respiratory Diseases Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Artificial Intelligence (AI) In Respiratory Diseases Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Artificial Intelligence (AI) In Respiratory Diseases Market Segmentation

    6.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Magnetic Resonance Imaging (MRI)

    Computed Tomography (CT) Scan

    Electronic Patient-Reported Outcomes (ePRO)

    6.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Chronic Obstructive Pulmonary Disease

    Interstitial Lung Disease

    Pulmonary Infection

    6.3. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital

    Diagnostic Centers

    Ambulatory Surgical Centers

    Other End-Users

    7. Artificial Intelligence (AI) In Respiratory Diseases Market Regional And Country Analysis

    7.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market

    8.1. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Artificial Intelligence (AI) In Respiratory Diseases Market

    9.1. China Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    9.2. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Artificial Intelligence (AI) In Respiratory Diseases Market

    10.1. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Artificial Intelligence (AI) In Respiratory Diseases Market

    11.1. Japan Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    11.2. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Artificial Intelligence (AI) In Respiratory Diseases Market

    12.1. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market

    13.1. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market

    14.1. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    14.2. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market

    15.1. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    15.2. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Artificial Intelligence (AI) In Respiratory Diseases Market

    16.1. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Artificial Intelligence (AI) In Respiratory Diseases Market

    17.1. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Artificial Intelligence (AI) In Respiratory Diseases Market

    18.1. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Artificial Intelligence (AI) In Respiratory Diseases Market

    19.1. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Artificial Intelligence (AI) In Respiratory Diseases Market

    20.1. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market

    21.1. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    21.2. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Artificial Intelligence (AI) In Respiratory Diseases Market

    22.1. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Artificial Intelligence (AI) In Respiratory Diseases Market

    23.1. North America Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    23.2. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Artificial Intelligence (AI) In Respiratory Diseases Market

    24.1. USA Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    24.2. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Artificial Intelligence (AI) In Respiratory Diseases Market

    25.1. Canada Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    25.2. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Artificial Intelligence (AI) In Respiratory Diseases Market

    26.1. South America Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    26.2. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market

    27.1. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market

    28.1. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    28.2. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Artificial Intelligence (AI) In Respiratory Diseases Market

    29.1. Africa Artificial Intelligence (AI) In Respiratory Diseases Market Overview

    29.2. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape And Company Profiles

    30.1. Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape

    30.2. Artificial Intelligence (AI) In Respiratory Diseases Market Company Profiles

    30.2.1. Siemens Healthineers

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Philips Healthcare

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. General Electric (GE) Healthcare

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Verily Life Sciences LLC

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. DeepMind Health

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Artificial Intelligence (AI) In Respiratory Diseases Market Other Major And Innovative Companies

    31.1. Merative L.P.

    31.2. Innovaccer

    31.3. Freenome

    31.4. Aidoc Medical

    31.5. Butterfly Network

    31.6. Infervision

    31.7. Imagen Technologies

    31.8. Caption Health

    31.9. Gauss Surgical Inc.

    31.10. Swaasa AI

    31.11. Inspirata Inc.

    31.12. VIDA Diagnostics Inc.

    31.13. Enlitic

    31.14. Thirona B.v.

    31.15. ArtiQ

    32. Global Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Benchmarking

    33. Global Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Respiratory Diseases Market

    35. Artificial Intelligence (AI) In Respiratory Diseases Market Future Outlook and Potential Analysis

    35.1 Artificial Intelligence (AI) In Respiratory Diseases Market In 2028 - Countries Offering Most New Opportunities

    35.2 Artificial Intelligence (AI) In Respiratory Diseases Market In 2028 - Segments Offering Most New Opportunities

    35.3 Artificial Intelligence (AI) In Respiratory Diseases Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Siemens Healthineers Financial Performance
  • Table 75: Philips Healthcare Financial Performance
  • Table 76: General Electric (GE) Healthcare Financial Performance
  • Table 77: Verily Life Sciences LLC Financial Performance
  • Table 78: DeepMind Health Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Siemens Healthineers Financial Performance
  • Figure 75: Philips Healthcare Financial Performance
  • Figure 76: General Electric (GE) Healthcare Financial Performance
  • Figure 77: Verily Life Sciences LLC Financial Performance
  • Figure 78: DeepMind Health Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Artificial Intelligence Of Things (AIoT) Global Market Report 2024 – By Offering (Solutions, Services), By Deployment (On-Premises, Cloud), By Vertical (Banking, Financial Services and Insurance (BFSI), Manufacturing, Healthcare, Energy And Utilities, Retail, Transportation And Logistics, Other Verticals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence In Cancer Diagnostics Global Market Report 2024 – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types), By Application (Screening And Diagnosis, Tumor Identification, Surveillance, Treatment), By End-User (Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence (AI) Engineering Global Market Report 2024 – By Solution (Hardware, Software, Services), By Technology (Deep Learning, Machine Learning, Natural Language Processing, Computer Vision), By Deployment (On-Cloud, On-Premise), By End-User (Healthcare, Automotive And Transportation, Agriculture, Information Technology (IT), Business Management, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence In Magnetic Resonance Imaging (MRI) Global Market Report 2024 – By Offering (Hardware, Software, Services), By Technology (Deep Learning, Machine Learning, Computer Vision, NLP (Natural Language Processing), Speech Recognition, Querying Method, Other Technologies), By Deployment Type (On-Premise, Cloud), By Clinical Applications (Musculoskeletal, Colon, Prostate, Liver, Cardiovascular, Neurology, Lung, Breast, Other Clinical Applications), By End-User (Clinics, Research And Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Enterprise Artificial Intelligence Global Market Report 2024 – By Component (Solution, Service), By Technology (Machine Learning, Natural Language Processing (NLP), Image Processing, Speech Recognition), By Deployment Type (Cloud, On-Premise), By Application (Security And Risk Management, Marketing Management, Customer Support And Experience, Human Resource And Recruitment Management, Analytics Application, Process Automation), By Industry (Retail, Healthcare, Automotive, Banking And Financial Services, Media And Entertainment, Other Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence (AI) Camera Global Market Report 2024 – By Type (Smartphone Camera, Surveillance Camera, DSLR Camera, Other Types), By Technology (Image or Face Recognition, Voice or Speech Recognition, Computer Vision, Other Technologies), By End User (Banking, Financial Services and Insurance (BFSI), Healthcare, Automotive, Retail, Government, Logistics and Transportation, Military and Defense, Commercial Spaces, Media and Entertainment, Other End-Users ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence (AI) in Operating Room Global Market Report 2024 – By Offerings (Hardware, Software-As-A-Service (SaaS)), By Indication (Cardiology, Orthopedics, Urology, Gastroenterology, Neurology, Other Indications), By Technology (Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Computer Vision), By Application (Training And Supporting, Diagnosis And Monitoring, Outcome And Risk Analysis, Surgical Planning And Rehabilitation, Integration And Connectivity, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Standalone Or Specialized Facilities, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence Services Global Market Report 2024 – By Technology (Machine Learning, Computer Vision, Natural Language Processing (NLP), Other Technology), By Services Type (Managed Services, Professional Services), By Software Tools (Web-based and Cloud Application Programming Interface, Processing and Modeler, Archiving and Data Storage), By Application Type (Fraud Detection, Data Analytics & Visualization, Customer Service and Management, Risk Management, Compliance & Security), By End-User (Banking, Financial, and Insurance (BFSI), IT & Telecom, Retail, Manufacturing, Public Sector, Energy & Utility, Healthcare, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the artificial intelligence (AI) in respiratory diseases market?

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management. For further insights on the artificial intelligence (AI) in respiratory diseases market, request a sample here

How will the artificial intelligence (AI) in respiratory diseases market drivers and restraints affect the artificial intelligence (AI) in respiratory diseases market dynamics? What forces will shape the artificial intelligence (AI) in respiratory diseases industry going forward?

The artificial intelligence (AI) in respiratory diseases market major growth driver - AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution. For further insights on the artificial intelligence (AI) in respiratory diseases market, request a sample here

What is the forecast market size or the forecast market value of the artificial intelligence (AI) in respiratory diseases market?

The AI in respiratory diseases market size has grown strongly in recent years. It will grow from $7.25 billion in 2023 to $7.66 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing government regulations, growing environmental concerns, increasing aging population, growing patient-centric healthcare approaches, rise in healthcare infrastructure development. The AI in respiratory diseases market size is expected to see steady growth in the next few years. It will grow to $9.35 billion in 2028 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring. For further insights on the artificial intelligence (AI) in respiratory diseases market, request a sample here

How is the artificial intelligence (AI) in respiratory diseases market segmented?

The artificial intelligence (AI) in respiratory diseases market is segmented
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-UsersFor further insights on the artificial intelligence (AI) in respiratory diseases market, request a sample here

Which region has the largest share of the artificial intelligence (AI) in respiratory diseases market? What are the other regions covered in the report?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the artificial intelligence (AI) in respiratory diseases market, request a sample here.

Who are the major players in the artificial intelligence (AI) in respiratory diseases market?

Major companies operating in the artificial intelligence (ai) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ , Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd. For further insights on the artificial intelligence (AI) in respiratory diseases market, request a sample here.

What are the key trends in the artificial intelligence (AI) in respiratory diseases market?

Major trend in the artificial intelligence (AI) in respiratory diseases market - TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management. For further insights on the artificial intelligence (AI) in respiratory diseases market, request a sample here.

What are the major opportunities in the artificial intelligence (AI) in respiratory diseases market? What are the strategies for the artificial intelligence (AI) in respiratory diseases market?

For detailed insights on the major opportunities and strategies in the artificial intelligence (AI) in respiratory diseases market, request a sample here.

How does the artificial intelligence (AI) in respiratory diseases market relate to the overall economy and other similar markets?

For detailed insights on artificial intelligence (AI) in respiratory diseases market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the artificial intelligence (AI) in respiratory diseases industry?

For detailed insights on the mergers and acquisitions in the artificial intelligence (AI) in respiratory diseases industry, request a sample here.

What are the key dynamics influencing the artificial intelligence (AI) in respiratory diseases market growth? SWOT analysis of the artificial intelligence (AI) in respiratory diseases market.

For detailed insights on the key dynamics influencing the artificial intelligence (AI) in respiratory diseases market growth and SWOT analysis of the artificial intelligence (AI) in respiratory diseases industry, request a sample here.